2:40 pm

Presentation of Zometa as a case example

 

Larry Lesko, Ph.D.

Director, Office of Clinical Pharmacology and Biopharmaceutics, U.S. Food and Drug Administration

3:00 pm

Discuss how new approaches could work with the case example (Zometa)

(15 minute presentations)

 

Discussion Leader: Jeffrey Leiden, M.D., Ph.D.

 

Lisa Schwartz, M.D., M.S.

Associate Professor of Medicine and Community and Family Medicine, Dartmouth University

 

Kevin A. Schulman, M.D.

Professor of Medicine, Duke University

 

Mark Fendrick, M.D.

Professor, Department of Internal Medicine, University of Michigan

4:00 pm

Discussion

4:35 pm

Next Steps

5:30 pm

Adjourn



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement